Implicit ethical choices in ultra-rare therapy development: researchers' perspectives on patient selection and communication, therapy value, and accessibility
{{output}}
Background: The development of new highly technological and highly personalized therapies for ultra-rare diseases is one of the fast-advancing areas in biomedicine. Yet such an approach is experimental, resource-intensive, and ac... ...
